These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 931393)

  • 21. LongoVital and herpes labialis: a randomised, double-blind, placebo-controlled study.
    Pedersen A
    Oral Dis; 2001 Jul; 7(4):221-5. PubMed ID: 11575872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of herpes labialis with acyclovir. Review of three clinical trials.
    Raborn GW; McGaw WT; Grace M; Percy J
    Am J Med; 1988 Aug; 85(2A):39-42. PubMed ID: 3044091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of recurrent herpes simplex labialis with topical butylated hydroxytoluene.
    Freeman DJ; Wenerstrom G; Spruance SL
    Clin Pharmacol Ther; 1985 Jul; 38(1):56-9. PubMed ID: 2988845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical comparison of two topical antiviral ointments in herpes].
    Makleit L; Nagy M
    Orv Hetil; 1995 Feb; 136(8):417-9. PubMed ID: 7885687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical trial of topically applied 3 percent vidarabine against recurrent herpes labialis.
    Rowe NH; Brooks SL; Young SK; Spencer J; Petrick TJ; Buchanan RA; Drach JC; Shipman C
    Oral Surg Oral Med Oral Pathol; 1979 Feb; 47(2):142-7. PubMed ID: 218154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on short-course intermittent and prevention therapies for herpes labialis.
    Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
    Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
    Kinghorn GR
    Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine.
    Godfrey HR; Godfrey NJ; Godfrey JC; Riley D
    Altern Ther Health Med; 2001; 7(3):49-56. PubMed ID: 11347285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir.
    Spruance SL; Crumpacker CS; Schnipper LE; Kern ER; Marlowe S; Arndt KA; Overall JC
    Antimicrob Agents Chemother; 1984 May; 25(5):553-5. PubMed ID: 6732224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of recurrent oral aphthous and herpetic ulcerations.
    Lichon JF
    Dent Today; 1994 Oct; 13(10):88-9. PubMed ID: 9540582
    [No Abstract]   [Full Text] [Related]  

  • 31. [Yellow fever vaccination as prophylaxis of herpes labialis].
    Møller A; Andersen PL; Korsager B; Black FT
    Ugeskr Laeger; 1997 Apr; 159(15):2228-9. PubMed ID: 9148548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lysine therapy of recurrent herpes simplex labialis].
    Milman N; Jessen O; Scheibel J
    Ugeskr Laeger; 1979 Oct; 141(43):2960-2. PubMed ID: 392853
    [No Abstract]   [Full Text] [Related]  

  • 33. Determining therapeutic efficacy in recurrent herpes labialis by lesion size analysis.
    Rodu B; Russell CM; Mattingly G
    Oral Surg Oral Med Oral Pathol; 1991 Aug; 72(2):178-83. PubMed ID: 1923396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial.
    Spruance SL; Stewart JC; Freeman DJ; Brightman VJ; Cox JL; Wenerstrom G; McKeough MB; Rowe NH
    J Infect Dis; 1990 Feb; 161(2):191-7. PubMed ID: 2153736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical lipophilic epigallocatechin-3-gallate on herpes labialis: a phase II clinical trial of AverTeaX formula.
    Zhao M; Zheng R; Jiang J; Dickinson D; Fu B; Chu TC; Lee LH; Pearl H; Hsu S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Dec; 120(6):717-24. PubMed ID: 26548726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of post-marketing surveillance].
    Gross G; Braun D
    Hautarzt; 2006 Jan; 57(1):40-6. PubMed ID: 16258759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy of low-level light therapy using 1072 nm infrared light for the treatment of herpes simplex labialis.
    Dougal G; Lee SY
    Clin Exp Dermatol; 2013 Oct; 38(7):713-8. PubMed ID: 23731454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, controlled trial of levamisole in the treatment of recurrent herpes labialis.
    Russell AS; Brisson E; Grace M
    J Infect Dis; 1978 May; 137(5):597-600. PubMed ID: 351073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding recurrent herpes labialis management and impact on patients' quality of life: the HERPESCOPE study.
    Dreno B; Malkin JE; Saiag P
    Eur J Dermatol; 2013; 23(4):491-9. PubMed ID: 24004686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of lysine treatment in recurrent herpes simplex labialis.
    Milman N; Scheibel J; Jessen O
    Lancet; 1978 Oct; 2(8096):942. PubMed ID: 81954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.